HOME
CONTACT
ALL
V-Bio News
Portfolio News
Newsletter
V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases
v-bio-ventures
2019-12-16T13:16:58+00:00
December 16th, 2019
|
V-Bio News
|
Read More
V-Bio Ventures leads AgomAb Therapeutics’ Euros 21m Series A Financing
v-bio-ventures
2019-04-03T08:21:45+00:00
April 3rd, 2019
|
V-Bio News
|
Read More
V-Bio Ventures leads Camel-IDS EUR 37m Series A financing to develop cancer targeted radiopharmaceuticals
v-bio-ventures
2018-11-27T19:46:39+00:00
November 15th, 2018
|
V-Bio News
|
Read More
V-Bio Ventures participates in 22.5 million euros series B financing round of HORAMA
v-bio-ventures
2018-09-20T10:11:13+00:00
September 18th, 2018
|
V-Bio News
|
Read More
V-Bio Ventures invests in UCB spinout Syndesi Therapeutics to develop novel therapeutics for cognitive disorders
v-bio-ventures
2018-03-11T08:34:49+00:00
February 1st, 2018
|
V-Bio News
|
Read More
V-Bio Ventures leads EUR 7.7M financing of Aphea.Bio
v-bio-ventures
2017-10-09T09:22:31+00:00
June 16th, 2017
|
V-Bio News
|
Read More
V-Bio Ventures invests in OCTIMET Oncology
v-bio-ventures
2017-10-09T09:22:27+00:00
January 19th, 2017
|
V-Bio News
|
Read More
V-Bio Ventures closes first life sciences fund, raising over € 75 million
v-bio-ventures
2017-10-09T09:22:18+00:00
December 1st, 2016
|
V-Bio News
|
Read More
V-Bio Ventures invests in VIB spinout Confo Therapeutics NV
v-bio-ventures
2017-10-09T09:21:58+00:00
February 2nd, 2016
|
V-Bio News
|
Read More
First Closing of V-Bio Ventures Fund 1 with commitments of € 63 million
v-bio-ventures
2017-10-13T15:24:37+00:00
November 19th, 2015
|
V-Bio News
|
Read More
